Real Time PCR Systems Market: By Product (Halogen, LED, Others, instruments, Reagents and Consumables, Services and Software), By Application (Clinical Applications (Blood Testing, Oncology Testing, Pathogen Testing, Others), Research Applications, Forensic Applications), By End User (Hospitals, Diagnostic Centers, Research Laboratories, Academic Institutes, Forensic Laboratories, Clinical Research Organizations, Clinics),and Geography     

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Real-Time PCR Systems Market was valued at USD 30.48 billion in 2021 and is anticipated to grow at USD 52.92 billion by 2028, recording a CAGR of 8.2% during the forecast period 2022-2028. PCR is technique used to amplify a specific segment of DNA through thermal cycling protocol. Real-time PCR is a type of PCR technique where data are collected in real time as reaction proceeds. Real Time PCR Systems Market used for sensitive, specific detection and quantification of nucleic act targets. Innovation in technological advancements in PCR technology, growing prevalence of genetic disorders and infectious diseases drives the growth of the portable PCR devices market. Furthermore, growing investments by the governments and private companies on PCR techniques, growing market penetration in developing countries and raising usage of biomarker profiling in diagnosis of disease also propels the growth of the portable PCR technique. However, high cost associated with the devices, dearth of skilled labors may hamper the growth of the portable PCR devices. PCR systems are laboratory instruments that amplify copies of a specific DNA sequence in real time. The market is growing due to the rising prevalence of chronic and infectious diseases. Furthermore, the advancements in various sectors such as forensics, diagnostics, and proteomics research is creating the potential growth opportunities for market.

Real Time Pcr Systems Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Real-Time PCR Systems Market Dynamics Growth

Real-Time PCR systems are widely used in detection of disease and clinical and research applications. Players are also focussing on various growth strategies such as new product launches and development, acquisitions, collaborations and partnerships to enhance their market presence in global Real Time PCR systems market. For Instance, in March 2017, Thermo Fisher Scientific launched QuantStudio 5 Real Time PCR system for human identification useful in modern forensic labs.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Real Time Pcr Systems Market Segmentation

  • Halogen
  • LED
  • Others
  • Instruments
  • Reagents and Consumables
  • Services and Software
  • Clinical Applications
  • Blood Testing
  • Oncology Testing
  • Pathogen Testing
  • Others
  • Research Applications
  • Forensic Applications
End User
  • Hospitals
  • Diagnostic Centers
  • Research Laboratories
  • Academic Institutes
  • Forensic Laboratories
  • Clinical Research Organizations
  • Clinics
By Geography
North America
  • US
  • Canada
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe
  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific
Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
Middle East and Africa (MEA)
  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA


Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • Bio-Rad Laboratories Inc. (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • QIAGEN N.V. (Netherlands)
  • Hoffmann-La Roche Ltd. (Switzerland)
  • Agilent Technologies, Inc. (U.S.)
  • Takara Bio Inc. (Japan)
  • Fluidigm Corporation (U.S.)
  • bioMérieux S.A. (France)
  • Danaher Corporation (U.S.)
  • Abbot Laboratories (U.S.)